InvestorsHub Logo

C C

Followers 228
Posts 23772
Boards Moderated 5
Alias Born 03/30/2006

C C

Re: simplegreen post# 4031

Saturday, 12/23/2006 2:32:18 PM

Saturday, December 23, 2006 2:32:18 PM

Post# of 140146
simplegreen......recent PR's have caused the rise in pps
I believe we have hit bottom...the story is begining to unfold
We may be starting to hit the PR cycle...
http://new.quote.com/stocks/news.action?s=DNAG

both articles below are to be discussed in The Journal of Pharmacogenetics and Genomics (JPG).


notice these two important PR's

I find the most important one...the first spike came from this PR:
December 8
DNAPrint Pharmaceuticals / Harvard Study Shows PT-401 to Be Three Times More Potent Than Conventional EPOs in Treating Anemia, and conclude that PT-401 has "biological activities superior to those of EPO monomer, suggesting important therapeutic advantages."
The results of the study will be formally presented by Drs. Jee-Yeong Jeong and Arthur J. Sytkowski on Dec. 9, 2006, at the American Society of Hematology 48th Annual Meeting and Exposition in Orlando, Fla.

http://biz.yahoo.com/iw/061208/0192814.html



another PR:

Dec 19
DNAPrint Genomics, Inc. (OTCBB: DNAG), today announced that the Company's research staff has discovered a genetic marker for statin-induced myalgia (chronic muscle pain), that a patent has been filed to protect the discovery and that the research on which the discovery is based will be published in an upcoming issue of The Journal of Pharmacogenetics and Genomics (JPG).

http://new.quote.com/stocks/story.action?id=INW353u4902

DNAG CHART:

http://stockcharts.com/h-sc/ui?s=DNAG&p=D&yr=0&mn=3&dy=0&id=p89881256073


cha-ching





I invest strictly off charts......do ur own DD


I invest in stocks that trade 500,000 + shares a day
DO NOT BUY OR SELL SECURITIES BASED ON ANYTHING THAT I POST


.


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.